(Q43636274)

25 November 2017

Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure (English)

1 reference

25 November 2017

heart rate variability

0 references

0 references

1 reference

congestive heart failure

1 reference

3

1 reference

25 November 2017

Yee KM

1

1 reference

PubMed ID

11401114

25 November 2017

Pringle SD

series ordinal

2

1 reference

PubMed ID

11401114

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Journal of the American College of Cardiology

25 November 2017

1 reference

25 November 2017

37

1 reference

25 November 2017

7

1 reference

25 November 2017

1800-1807

1 reference

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Aldosterone reduces baroreceptor discharge in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Aldosterone blunts the baroreflex response in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Diurnal variations of plasma aldosterone in supine man: relationship to plasma renin activity and plasma cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Spontaneous Variability and Circadian Distribution of Ectopic Activity in Patients With Malignant Ventricular Arrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Circadian variation in the frequency of onset of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Timing of sudden death in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Determination of norepinephrine apparent release rate and clearance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Twenty-four-hour spectral analysis of heart rate variability in congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Decreased spontaneous heart rate variability in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Assessment of autonomic tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Digoxin reduces cardiac sympathetic activity in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Circadian variation of QT interval dispersion: correlation with heart rate variability.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

QT interval prolongation as predictor of sudden death in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Reduction in QT dispersion by sotalol following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to-moderate heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Relation of Electrolyte Disturbances to Cardiac Arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Observations in experimental magnesium depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Magnesium therapy for torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

Normalization of acquired QT prolongation in humans by intravenous potassium.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901243-8

7 January 2021

10.1016/S0735-1097(01)01243-8

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

11401114